Long-acting GLP-1 receptor agonist

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Long-acting GLP-1 receptor agonist, covering 2017-02-27 to 2017-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects [Phase 1]